Download - UROP presentation
![Page 1: UROP presentation](https://reader036.vdocument.in/reader036/viewer/2022062503/58e49ac21a28abf5428b4f17/html5/thumbnails/1.jpg)
THE INVADING MECHANISM OF PLAMODIUM VIVAX
ASSOCIATED WITH DUFFY-NEGATIVES FROM THE
ETHIOPIAN POPULATIONSKristie Hanh Bich NguyenDr. Guiyun Yan Post-doc Eugenia Lo
![Page 2: UROP presentation](https://reader036.vdocument.in/reader036/viewer/2022062503/58e49ac21a28abf5428b4f17/html5/thumbnails/2.jpg)
CONTENTS
• WHY should we care about malaria?• WHO are in danger?• WHAT is malaria?• HOW should we approach it?
![Page 3: UROP presentation](https://reader036.vdocument.in/reader036/viewer/2022062503/58e49ac21a28abf5428b4f17/html5/thumbnails/3.jpg)
WHY SHOULD WE CARE ABOUT MALARIA?
• Number of Malaria cases is 214 million (2015)
• Number of people at risk of malaria infection is 3.3 million
• 3.45 million people are not at risk
• ~80% of cases occurred in Africa, 12% in South Asia, and 5% in Eastern Mediterranean region
![Page 4: UROP presentation](https://reader036.vdocument.in/reader036/viewer/2022062503/58e49ac21a28abf5428b4f17/html5/thumbnails/4.jpg)
WHO ARE IN DANGER?• It locates in the North of
Africa• All age groups are at risk,
and mortality rate is high among children under age of 5
• Plasmodium Falciparum and Plasmodium Vivax are the two most dominant malaria parasites in Ethiopia
![Page 5: UROP presentation](https://reader036.vdocument.in/reader036/viewer/2022062503/58e49ac21a28abf5428b4f17/html5/thumbnails/5.jpg)
WHAT IS MALARIA?(VECTOR-BORNE DISEASE)
• Transmitted by female Anopheles mosquito
• Plasmodium parasitesP. falciparum P. vivaxP. malariae P. ovale P. knowlesi
![Page 6: UROP presentation](https://reader036.vdocument.in/reader036/viewer/2022062503/58e49ac21a28abf5428b4f17/html5/thumbnails/6.jpg)
INVADING MECHANISM
![Page 7: UROP presentation](https://reader036.vdocument.in/reader036/viewer/2022062503/58e49ac21a28abf5428b4f17/html5/thumbnails/7.jpg)
Malaria
Evolution
Infection
Growth
![Page 8: UROP presentation](https://reader036.vdocument.in/reader036/viewer/2022062503/58e49ac21a28abf5428b4f17/html5/thumbnails/8.jpg)
CLINICAL CHALLENGE
• Humans lacking Duffy antigen resistant to P. vivax1
• The human DARC gene determines the presence of Duffy2
• P. vivax recently evolved the capability to infect Duffy (-)3
• Parasites becoming more prevalent and widespread3
Duffy (-)
Duffy (+)
![Page 9: UROP presentation](https://reader036.vdocument.in/reader036/viewer/2022062503/58e49ac21a28abf5428b4f17/html5/thumbnails/9.jpg)
INVADING MECHANISM
![Page 10: UROP presentation](https://reader036.vdocument.in/reader036/viewer/2022062503/58e49ac21a28abf5428b4f17/html5/thumbnails/10.jpg)
• DBP II is a 330 amino acid region characterized by 12 conserved cysteine residues
• The central 170-aa that includes cysteine 4-7 are critical binding residues
• Any key mutations in PvDBP II of Duffy-negative red cells?
PVDBP REGION II POLYMORPHISM
![Page 11: UROP presentation](https://reader036.vdocument.in/reader036/viewer/2022062503/58e49ac21a28abf5428b4f17/html5/thumbnails/11.jpg)
HOW SHOULD WE APPROACH IT?
What is the proportion of Duffy-negative in local populations?
What is the frequency of P.Vivax infection among the Duffy-negatives?
What is P.Vivax’s invading mechanism to Duffy-negative population?
![Page 12: UROP presentation](https://reader036.vdocument.in/reader036/viewer/2022062503/58e49ac21a28abf5428b4f17/html5/thumbnails/12.jpg)
METHODOLOGIES
Sample collection
DNA purification
Parasite detection
![Page 13: UROP presentation](https://reader036.vdocument.in/reader036/viewer/2022062503/58e49ac21a28abf5428b4f17/html5/thumbnails/13.jpg)
NESTED POLYMERASE CHAIN REACTION (NESTED PCR)
![Page 14: UROP presentation](https://reader036.vdocument.in/reader036/viewer/2022062503/58e49ac21a28abf5428b4f17/html5/thumbnails/14.jpg)
QUANTITATIVE REAL-TIME PCR (QPCR)
Well CqE1 27.05E2 N/AE3 26.54E4 N/AE5 25.70E6 N/AE11 N/AE12 N/AF1 43.30F2 N/AF3 N/AF4 30.20
![Page 15: UROP presentation](https://reader036.vdocument.in/reader036/viewer/2022062503/58e49ac21a28abf5428b4f17/html5/thumbnails/15.jpg)
Based on nested PCR and qPCR assays Based on DARC
Site Sample size Falciparum only Vivax only Co-infectionDuffy genotype
of vivax infection Alaba 49 18 1 0 1 +Mankush 298 179 41 33 73 +; 1-Metehara 275 151 97 11 107+; 1 -Jimma 104 8 92 0 91 +; 1- Asendabo 390 49 23 1 21+; 2-
SUMMARY OF MALARIA INFECTION IN ETHIOPIA
![Page 16: UROP presentation](https://reader036.vdocument.in/reader036/viewer/2022062503/58e49ac21a28abf5428b4f17/html5/thumbnails/16.jpg)
TWO CONTENT LAYOUT WITH SMARTART• First bullet point here• Second bullet point here• Third bullet point here
Group A
• Task 1
• Task 2
Group B
• Task 1
• Task 2
Group C
![Page 17: UROP presentation](https://reader036.vdocument.in/reader036/viewer/2022062503/58e49ac21a28abf5428b4f17/html5/thumbnails/17.jpg)
IDEAS?• Migration to different areas in Africa• Prevention• Vaccine production
![Page 18: UROP presentation](https://reader036.vdocument.in/reader036/viewer/2022062503/58e49ac21a28abf5428b4f17/html5/thumbnails/18.jpg)